RPL5A Antibody

Shipped with Ice Packs
In Stock

Description

Developmental Defects and Ribosomopathies

  • Xenopus laevis model: RPL5 knockdown caused microcephaly, eye malformations, and cranial cartilage defects, mimicking DBA phenotypes. Apoptosis and reduced neural crest marker expression were observed .

  • DBA patients: Germline RPL5 mutations correlate with elevated cancer risk due to defective DNA repair (e.g., reduced RAD51 levels impair homologous recombination) .

Cancer Biology

  • Tumor suppressor role: RPL5 haploinsufficiency occurs in 11–34% of glioblastoma, melanoma, and breast cancers. Knockdown accelerates tumor growth in xenograft models .

  • Mechanistic insights:

    • RPL5 deficiency reduces BRCA2 and PARP1 levels, impairing DNA repair .

    • Altered c-Myc and p53 signaling exacerbates proliferation defects .

Plant Studies

  • Arabidopsis thaliana: RPL5A regulates auxin response factors (ARF5/ARF7) via translational control, affecting root gravitropism .

Clinical and Therapeutic Implications

  • Diagnostic potential: RPL5 antibodies aid in detecting ribosomopathies and cancers with ribosomal dysfunction.

  • Therapeutic targets: Restoring RPL5 function or modulating its interactions (e.g., with MDM2) could mitigate DBA or cancer progression .

Technical Considerations for Antibody Use

  • Western blotting: Use 30–50 µg lysate and 10–12% SDS-PAGE for optimal 34 kDa band resolution .

  • IHC/IF: Antigen retrieval (e.g., citrate buffer) enhances signal in formalin-fixed tissues .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RPL5A antibody; AE6 antibody; ATL5 antibody; OLI5 antibody; PGY3 antibody; At3g25520 antibody; MWL2.17 antibody; 60S ribosomal protein L5-1 antibody; Ribosomal protein L5 A antibody; Protein ASYMMETRIC LEAVES1/2 ENHANCER 6 antibody; Protein OLIGOCELLULA 5 antibody; Protein PIGGYBACK 3 antibody
Target Names
RPL5A
Uniprot No.

Target Background

Function
Ribosomal protein L5A is a fundamental component of the ribosome, a complex macromolecule essential for protein synthesis within cells. As part of the small ribosomal subunit (SSU), it plays a crucial role in decoding messenger RNA (mRNA) sequences and selecting the appropriate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) houses the peptidyl transferase center (PTC), the catalytic site responsible for forming peptide bonds during polypeptide chain elongation. Nascent polypeptides exit the ribosome through a tunnel in the LSU, where they interact with protein factors that facilitate enzymatic processing, targeting, and membrane insertion. Additionally, RPL5A is implicated in regulating cell proliferation and establishing leaf polarity in plants, potentially contributing to the translation-mediated specification of leaf adaxial identity.
Gene References Into Functions
  1. Research indicates that Arabidopsis thaliana L5 and TFIIIA bind potato spindle tuber viroid (+) RNA in vitro with an affinity comparable to their binding of 5S rRNA. However, the affinity for a chloroplastic viroid is significantly lower. PMID: 21153748
Database Links

KEGG: ath:AT3G25520

STRING: 3702.AT3G25520.1

UniGene: At.23809

Protein Families
Universal ribosomal protein uL18 family
Subcellular Location
Cytoplasm. Nucleus. Nucleus, nucleolus. Nucleus, nucleoplasm.
Tissue Specificity
Expressed in seedlings, roots, stems, leaves, inflorescences and siliques.

Q&A

What is RPL5A and what cellular functions does it serve?

RPL5A is a ribosomal protein that plays a critical role in ribosome assembly and function. In Arabidopsis thaliana, RPL5A has been shown to modulate auxin responses through the translational regulation of multiple ARF (Auxin Response Factor)-containing 5′-leader sequences . This regulatory function is essential for proper plant development, affecting processes such as leaf morphology, vascular development, and the establishment of lateral organ boundaries . RPL5A functions in conjunction with other ribosomal proteins like RPL4A and RPL4D in these developmental pathways.

How do RPL5A mutations manifest phenotypically in research models?

Studies in Arabidopsis have demonstrated that RPL5A mutations produce distinct developmental abnormalities. These include narrow, pointed first leaves, defective establishment of lateral organ boundaries (causing mild fusions of cauline leaves to the stem), and aberrant vascular development that deviates from the normal reticulate pattern . Importantly, the severity of these phenotypes can vary significantly depending on the genetic background, with mutations in the Landsberg erecta (Ler) background displaying more pronounced effects compared to the Columbia (Col) background .

What are the critical considerations when designing flow cytometry experiments with RPL5A antibodies?

When designing flow cytometry experiments using RPL5A antibodies, researchers should first perform thorough background checks on the target protein's expression patterns and select appropriate cell lines known to express RPL5A as positive controls . Since RPL5A is an intracellular protein associated with ribosomes, proper fixation and permeabilization protocols are essential to allow antibody access to the target. Additionally, researchers must carefully validate the antibody's specificity through appropriate controls and optimize blocking conditions to minimize non-specific binding .

The following considerations are essential for successful experimental design:

  • Select flow-validated antibodies whenever possible

  • Determine the cellular localization of RPL5A in your model system

  • Choose appropriate fixation and permeabilization methods

  • Implement proper controls to demonstrate specificity

  • Optimize blocking conditions to reduce background signal

  • Maintain proper cell concentration (105-106 cells) to avoid clogging the flow cell

What controls should be included when working with RPL5A antibodies in flow cytometry?

To ensure reliable and reproducible results, four essential controls should be included when using RPL5A antibodies in flow cytometry:

Control TypePurposeImplementation
Unstained cellsDetermine baseline autofluorescenceProcess cells through all steps except antibody addition
Negative cellsVerify antibody specificityUse cell populations not expressing RPL5A
Isotype controlAssess non-specific binding via Fc receptorsUse same antibody class with no known specificity in target cells
Secondary antibody onlyEvaluate non-specific binding of secondary antibodyOmit primary antibody, apply only labeled secondary antibody

These controls help distinguish genuine RPL5A signal from background noise and non-specific interactions, which is crucial for accurate data interpretation .

How does RPL5A contribute to translational regulation mechanisms in developmental pathways?

In plant systems, RPL5A has been identified as a critical component for translational regulation of multiple ARF-containing 5′-leader sequences . This regulation appears to be part of a complex ribosomal protein-mediated control system that modulates auxin responses during development. Research suggests that RPL5A, along with other ribosomal components such as RPL4A and RPL4D, may selectively regulate the translation of specific mRNAs, particularly those with uORFs (upstream Open Reading Frames) in their 5' leader sequences .

This translational control mechanism provides an additional layer of regulation beyond transcriptional control, allowing for fine-tuning of developmental programs. The genetic evidence demonstrates that proper translational regulation of ARFs involving uORFs is required for normal auxin-mediated developmental processes .

How can RPL5A antibodies be used to study ribosome heterogeneity and specialized ribosomes?

RPL5A antibodies can be valuable tools for investigating ribosome heterogeneity - the concept that ribosomes may vary in composition and function depending on cellular context. By immunoprecipitating RPL5A-containing complexes and performing comparative proteomic analyses, researchers can identify proteins that specifically interact with RPL5A-containing ribosomes.

This approach can help determine whether RPL5A contributes to the formation of specialized ribosomes that preferentially translate specific subsets of mRNAs. Such studies would typically involve:

  • Immunoprecipitation using RPL5A antibodies

  • Mass spectrometry analysis of co-precipitated proteins

  • RNA sequencing of associated mRNAs

  • Comparative analysis with control ribosomes or different ribosomal protein immunoprecipitations

These methods can provide insights into whether RPL5A confers specialized translational capabilities to ribosomes, similar to how NBR1 has been shown to interact with specific heat shock proteins for targeted degradation in stress response systems .

What fixation and permeabilization protocols are optimal for RPL5A detection in different experimental systems?

The optimal fixation and permeabilization protocol depends on the cellular location of RPL5A and the experimental system being used. Since RPL5A is an intracellular ribosomal protein, proper membrane permeabilization is essential for antibody accessibility. The following protocols are recommended:

For flow cytometry applications:

  • Fix cells with 1-2% paraformaldehyde (PFA) for 10-15 minutes at room temperature

  • Permeabilize with 0.1-0.5% Triton X-100 or 0.5% saponin in PBS for 5-10 minutes

For immunofluorescence microscopy:

  • Fix cells with 4% PFA for 15-20 minutes

  • Permeabilize with 0.2% Triton X-100 for 10 minutes

It is crucial to perform all steps on ice to prevent protein degradation and maintain cellular integrity. Additionally, washing steps should use PBS containing 0.1% sodium azide to prevent internalization of membrane antigens .

What blocking strategies minimize background when using RPL5A antibodies?

Effective blocking is essential for reducing non-specific binding and improving signal-to-noise ratios. For RPL5A antibody applications, consider the following blocking strategies:

  • Use 10% normal serum from the same host species as the labeled secondary antibody (but NOT from the same species as the primary antibody)

  • For highly conserved proteins like ribosomal components, non-serum blocking agents such as purified casein or albumin may be more effective to prevent primary antibody absorption

  • If working with immune cell-derived targets or immortalized immune variant cell lines, specific Fc receptor blocking solutions should be employed to prevent false positive results due to Fc receptor binding

  • Optimize blocking time and temperature - typically 30-60 minutes at room temperature or 4°C

When encountering high background issues, sequential application of different blocking agents (e.g., Fc block followed by serum or BSA blocking) may provide superior results.

How can researchers distinguish between specific RPL5A signal and artifacts in flow cytometry data?

Distinguishing genuine RPL5A signal from artifacts requires careful analysis and comparison with appropriate controls. Consider these approaches:

  • Compare fluorescence intensity with unstained controls to account for autofluorescence

  • Use fluorescence-minus-one (FMO) controls to set proper gating boundaries

  • Verify antibody specificity through knockdown/knockout validation when possible

  • Examine signal patterns across different cell populations - genuine RPL5A signal should correlate with expected expression patterns

  • Perform titration experiments with the antibody to identify optimal concentration that maximizes specific signal while minimizing background

Dead cells often contribute to false positive results due to non-specific binding of antibodies. Ensure cell viability exceeds 90% and include viability dyes in your panel to exclude dead cells from analysis .

How does genetic background influence RPL5A expression and antibody detection?

Genetic background can significantly impact RPL5A expression patterns and consequently antibody detection. Research in Arabidopsis has demonstrated that while RPL5A mutations in the Columbia (Col) background display relatively mild phenotypes, the same mutations in the Landsberg erecta (Ler) background result in much more severe developmental abnormalities .

This genetic background effect suggests potential variations in:

  • Expression levels of RPL5A in different genetic contexts

  • Compensation mechanisms (redundancy with other ribosomal proteins)

  • Modifier genes that interact with RPL5A function

  • Post-translational modifications affecting antibody epitope accessibility

When designing experiments using RPL5A antibodies, researchers should consider these potential background effects and validate antibody performance in their specific genetic context. Including wild-type controls from the same genetic background is essential for proper interpretation of results.

What approaches can resolve weak or inconsistent RPL5A antibody signals?

When encountering weak or inconsistent signals with RPL5A antibodies, consider these troubleshooting approaches:

  • Optimize antibody concentration through titration experiments

  • Evaluate different fixation and permeabilization protocols - ribosomal proteins may require specific conditions for optimal epitope exposure

  • Extend primary antibody incubation time (overnight at 4°C) to improve binding

  • Use signal amplification methods such as biotin-streptavidin systems or tyramide signal amplification

  • Ensure proper cell preparation - maintain cold temperatures throughout the protocol to prevent protein degradation

  • Check antibody storage conditions and expiration dates - degraded antibodies can lead to weak signals

  • Consider using a different clone or epitope if consistent problems persist

Remember that starting with higher cell numbers (e.g., 10^7 cells/tube) can help compensate for cell loss during multiple washing steps, thereby maintaining adequate signal strength .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.